Part II. Application not searched. Application not searched due to the presence of certain subject matter

Size: px
Start display at page:

Download "Part II. Application not searched. Application not searched due to the presence of certain subject matter"

Transcription

1 II.7. II.7.1. Application not searched This section relates to cases where the application relates entirely or in part to subject matter which the ISA is not required to search, or where all or part of the application fails to comply with the requirements of the PCT to such an extent that a meaningful search cannot be carried out. In such cases, the ISA will not search the application (or the part of the application affected) and will issue a declaration to inform the applicant and the IB of this. Where only part of the claimed invention is searched, the search report will be limited to exclude documents relevant to the affected part and this "partial search report" will be accompanied by a declaration. Those parts of the application which are not searched, need not be subject to the WO-ISA or to International Preliminary Examination (R66.1(e) PCT) It is the policy of the EPO not to prepare a WO- ISA or to perform International Preliminary Examination on subject matter which has not been searched. Application not searched due to the presence of certain subject matter No search report Art.17(2)(a)(i) PCT If the ISA considers that the International application relates to subject matter which it is not required to search according to the Rules, then the ISA informs the applicant and the IB that no search report will be prepared. Partial search report Art.17(2)(b) PCT Where the subject matter in question appears in certain claims and not others, then only the claims affected are excluded from the search and the search report indicates which claims have not been searched (a partial search report) and cites the relevant documents for the other claims according to Art.18 PCT. Art.17(2)(b) PCT & R43.9 PCT Where certain subject matter is searched and other subject matter is not searched, the search report must indicate which claims have been searched and which have not. Claims may also relate in part to subject matter which the ISA is not obliged to search and in part to subject matter which should be searched. This means that Art.17(2)(b) PCT is applied mutatis mutandis to part of a claim, see the example given in S&E-GL Excluded subject matter The subject matter which ISAs are not obliged to search is given in R39 PCT and corresponds to subject matter which is not considered patentable in many jurisdictions (including the EPC). The corresponding Article of the EPC, which forbids the patenting of the subject matter mentioned in R39 PCT is also given in the following sections II to II R39.1 PCT relating to: - scientific and mathematical theories - plant or animal varieties - essentially biological processes producing: - plants or - animals - schemes/rules/methods for doing business - schemes/rules/methods for mental acts - schemes/rules/methods for playing games - methods of treatment / diagnosis - presentations of information - computer programmes [For further explanations see the following sections II to II.7.1.6] Art.19 PCT Amendments not allowed PCT-AG I, 296 Where the ISA issues a declaration replacing the International search report under Art.17(2) PCT, the applicant is not Art.19 PCT. This is only applies where no search is performed at all - see "II.11 - Amendment under Art.19 PCT". Limitation of examination The EPO applies R43bis.1(b) PCT and R66.1(e) PCT and limits the scope of the examination in the WO-ISA to exclude from examination subject matter not searched due to Art.17(2)(a)(i) PCT & R39.1 PCT. Furthermore, where the EPO also acts as IPEA, the same subject matter excluded from International search and from examination in the WO-ISA by R66.1(e) PCT, is also excluded from International preliminary examination according to Art.34(4)(a)(i) PCT & R67.1 PCT. 116

2 R43bis.1(b) PCT [by reference to R70.2(d) PCT] & R66.2(a)(vi) PCT The WO-ISA or IPEA written opinion must indicate this limitation of the examination. Consequences in European phase T613/99 In the European regional phase, where the EPO acting as ISA has refused to search certain subject matter of the claims because they fall under the subject matter which may be excluded from the International search according to Art.17(2)(a)(i) PCT and R39.1 PCT, R86(4) EPC [since renumbered to R137(4) EPC and as of 1.Apr.2010 renumbered again to R137(5) EPC]* does not exclude such subject matter from forming the basis for further amendments in the European phase, even though it has not been searched (in this case the claims which were not searched in the PCT were reformulated into an allowable patentable form in the European regional phase). * According to R137(4) EPC [as of 1.Apr.2010 renumbered to R137(5) EPC]- amended claims may not relate to unsearched subject matter which does not combine with the original claimed invention or group of inventions to form a single general inventive concept. This rule was introduced to prevent a broad description from acting as a reservoir for amendment of the claims. In particular it prevents applicants hiding the true invention in the description and only introducing it into the claims after the search. However, the above decision found that subject matter present in the claims on filing, but not searched, because it was excluded from search by R39.1 PCT, can still form the basis for amendment of the claims in the European procedure. II R39.1(i) PCT II R39.1(ii) PCT Theories relating to scientific and mathematical theories See also Art.52(2)(a) EPC Plant, animal varieties relating to plant or animal varieties and essentially biological processes for the production thereof, except microbiological processes and the products thereof. See also Art.53(b) EPC II R39.1(iii) PCT OJ 2001, 482 & OJ 2002, 260 OJ 2009, 206 & OJ 2002, 52 II R39.1(iv) PCT Business methods etc relating to schemes, rules and methods of doing business, performing mental acts or playing games. See also Art.52(2)(c) EPC The EPO adopts a very strict approach with regard to applications for business methods. These are neither searched (R39.1(iii) PCT) nor examined (R67.1(iii) PCT) by the EPO as ISA and IPEA. Applications for business methods are also subject to the limitation of the EPO's competence as ISA, where the applicant is a resident or national of the USA (subject to the exception that if a national or resident of an EPC state is a co-applicant, then the limitation does not apply). For more details see "II Limitation of the EPO's competence as ISA". Methods of treatment / diagnosis relating to method of treatment* of the human or animal body by surgery or therapy and diagnostic methods. See also Art.53(c) EPC * The EPC explicitly forbids the patenting of methods of treatment of the human or animal body by surgery or therapy according to Art.53(c) EPC. When the EPO acts as ISA, it is not obliged to search claims directed to a method of treatment as such. However, when a claim formulated as a method of treatment relates to the use of a chemical compound for a method of treatment, the claim is searched taking into consideration how it could be reformulated in the European procedure in accordance with the decision G5/83 of the EPO Enlarged Board of Appeal (the Swiss type claim) or according to the formulation Compound/composition X, for use in treatment of disease Y [Art.54(4)(5) EPC]. Effectively a method of treatment claim characterised by the use of a certain chemical compound or group of chemical compounds will be searched by the EPO as ISA as though drafted in an allowable Swiss type or product for use format. 117

3 B-VIII, 2 A method of treatment claim not patentable according to Art.53(c) EPC is for example: "A method of treating disease X, by administering compound Y" A Swiss type claim, considered allowable under Art.53(c) EPC by the EPO Enlarged Board of Appeal (G5/83), reads thus: "Use of compound Y for the manufacture of a medicament, for the treatment of disease X" A product for use claim, considered allowable under Art.53(c) EPC reads thus: Compound/composition X, for use in treating disease Y Under the EPC, such a claim would be considered to be novel over the use of the same compound/composition in the treatment of a different disease [Art.54(5) EPC]. If, however, the claim relates to a method of treatment characterised by method features (e.g. dosage instructions), then the EPO may refuse to search the claim. The question of dosage methods is pending before the Enlarged Board of Appeal of the EPO under decision number G2/08. The contentious issue is: can a dosage feature be incorporated into a claim directed to a medicinal indication (Swiss claim or for use claim) of a compound or composition which dosage feature both differentiates that claim over the use of the same compound/composition in the treatment of the same disease in the prior art and is not excluded from patentability under Art.53(c) EPC? An example of such a situation is as follows: Prior art: Use of compound X for the treatment of disease Y and is administered once per day. Claim 1: Compound X, for use in the treatment of disease Y, wherein compound X is administered twice per day. The question posed by G2/08 is: can that claim 1 be novel over the prior art and also not be excluded from patentability under Art.53(c) EPC. If the Board of Appeal answers this question in the affirmative, the EPO might then change the above guideline and start to search such claims. II R39.1(v) PCT II R39.1(vi) PCT II.7.2. Presentations of information relating to presentations of information. See also Art.52(2)(d) EPC. Computer programmes The ISA is not required to search applications relating to computer programmes, to the extent that the ISA is not equipped to search them. See also Art.52(2)(c) EPC. Application not searched due to serious deficiencies No search report Art.17(2)(a)(ii) PCT Where the application has a description and/or claims and/or drawings which fail to comply with the prescribed PCT requirements to such an extent that no meaningful search is possible, then the ISA issues a declaration informing the applicant and the IB that no search report will be made. Partial search report Art.17(2)(b) PCT Where the unsearchable subject matter appears in certain claims and not others, then only the claims affected are excluded from the search and the search report indicates which claims have not been searched (a partial search report) and cites the relevant documents for the other claims according to Art.18 PCT. Art.17(2)(b) PCT & R43.9 PCT Where certain subject matter is searched and other subject matter is not searched, the search report must indicate which claims have been searched and which have not. Frequently, some claims relate in part to subject matter which cannot be searched and in part to subject matter which can be searched. In such cases, Art.17(2)(b) PCT is applied mutatis mutandis to part of a claim, see the example given in S&E-GL Deficiencies rendering meaningful search impossible Art.17(2)(a)(ii) PCT applies where the International application fails to conform to the requirements of the PCT, in particular those of clarity, conciseness and support of the claims (Art.6 PCT) and sufficiency of disclosure (Art.5 PCT) to such an extent, that the ISA is not able to perform a meaningful search. 118

4 The EPO has, since 2000, adopted a very strict policy with regard to this kind of application in particular in the areas of chemistry, biotechnology and telecommunications (see OJ 2000, 228). In these technical areas applicants often file applications with claims of such obscurity and great breadth that the examiner charged with the search is unable to determine what the claimed invention really is and consequently a search on the whole claimed scope is neither possible nor meaningful. These applications, often called "Complex Applications", usually warrant a partial search report limited to certain claimed subject matter which appears to represent the actual contribution which the applicant has made over the state of the art and this is usually derived from a dependent claim, or from the description. In cases of excessive numbers of claims, the examiner may refer to the description in an attempt to distil what has actually been invented (if anything). In the most serious cases no search report is issued at all (i.e. Art.17(2)(a)(ii) PCT is applied) and only a declaration replacing the search report in accordance with Art.17(2)(a) PCT is issued. Risks for the applicant When Art.17(2) PCT is applied, the ISA decides what to search and what not to search without any communication with the applicant. This is risky for the applicant, who cannot challenge this decision of the ISA. Furthermore, any subject matter excluded from the search need not be examined either in the WO- ISA or in PCT Chapter II (R66.1(e) PCT - the EPO makes strict use of this rule). The subject matter in question is only examined in as far as is necessary to demonstrate that it is so deficient that it cannot be searched or examined. This also carries the risk that the applicant might not be Art.19 PCT - see paragraph below: This finding cannot be challenged in the International phase. However, the applicant may challenge the findings which underlie a limitation of the search in the national or regional phase. If the applicant successfully argues his case in examination at the EPO, the EPO may perform an additional search free of charge during examination proceedings (C-VI, 8.2). Art.19 PCT amendments not allowed PCT-AG I, 296 Where the ISA issues a declaration replacing the International search report under Art.17(2) PCT, the applicant is not Art.19 PCT. For more details, see - "II.11 - Amendment under Art.19 PCT". Challenge by applicant The applicant has no way of challenging the partial search report or the reasons behind it once it has been issued (unlike the case of lack of unity). Novelty overflow There are cases where a claim, although clear, is drafted in such a way that the examiner retrieves so many documents pertinent to the novelty of that claim, that to cite them all is not feasible (overflow). In such cases, it is not meaningful to cite all of them, since it is clear that such claims cannot be maintained in later examination proceedings. The applicant will have to limit his application to a dependent claim or other preferred embodiments present elsewhere in the application. Failure to file a sequence listing R5.2(a) PCT & R13ter.1(b) PCT Where the International application disclosures one or more nucleic acid or amino acid sequences and the applicant has not already provided this, the ISA can require the applicant to supply a paper sequence listing (where the application is filed at least in part, on paper). R13ter.1(a) PCT The ISA can also require the applicant to file an electronic sequence listing, where the applicant has not already supplied this. R13ter.1(d) PCT Where the applicant has failed to file a paper and/or electronic sequence listing and/or pay the required late furnishing fee on time, the ISA can limit the search to the extent that the search cannot be carried out without them. See "II Biological sequence listings and International search". See the S&E-GL This possibility is used by the EPO. Time limit for preparing a declaration of no search / partial search report R42.1 PCT The declaration of a "no search" according to Art.17(2)(a) PCT must be issued within 119

5 S&E-GL 9.40 the same time limit as the International search report. See "II.6 - Time limit for completing the International search". The WO-ISA in limitation cases Where a declaration replacing the search report, or partial search report has been issued under Art.17 PCT, even if the ISA is not able to examine the issues of novelty, inventive step and industrial applicability, a WO-ISA is still prepared. For a "No Search" declaration replacing the search report, the WO-ISA simply addresses the issues which prevent an opinion on novelty, inventive step and industrial application from being given on the claimed subject matter. In the case of a partial search, the WO-ISA addresses novelty, inventive step and industrial application in as far as the application was searched (R66.1(e) PCT) and also addresses the issues which led to the search (and examination in the WO-ISA) being limited. II.8. II.8.1. Non-unity in International search Substantive issues Art.3(4)(iii) PCT The International application must comply with the prescribed requirement of unity of invention. Despite the stern language of Art.3(4)(iii) PCT, the sanction which applies when the International application does not comply with the requirement of unity of invention is only that the search and examination of the application in respect of inventions other than that first mentioned in the claims are conditional on the applicant paying further (search or examination) fees. The requirements of unity are prescribed in R13 PCT: R13.1 PCT An International application must relate to one invention only or to a group of inventions linked to form a single general inventive concept. R13.2 PCT Where an International application contains a group of inventions, unity is fulfilled only where there is a technical relationship among those inventions involving one or more common or corresponding special technical features A special technical feature is one which distinguishes the invention as a whole over the state of the art. R13.3 PCT If an International application contains a group of inventions, whether these appear in separate claims or as alternatives within a single claim is of no relevance for the judgement of unity. Dependent claims R13.4 PCT As long as the International application is unitary under R13.1 PCT, then a reasonable number of dependent claims is allowed, even if the features of any dependent claims could themselves be considered to be a separate invention. Those additional features characterising a dependent claim are taken in combination with the technical features of the independent claim which it depends on. As such the dependent claim contains the allegedly patentable and unifying features of the unitary independent claim. A posteriori non-unity G1/89 & G2/89 The EPO can request extra search fees under Art.17(3)(a) PCT, for a lack of unity a posteriori (i.e. where unity is found to be 120

Table 1: General overview of the PCT procedure Legend:

Table 1: General overview of the PCT procedure Legend: Table 1: General overview of the PCT procedure EPC: European Patent Convention EPO-OJ: EPO Official Journal RO: Receiving Office IB: International Bureau IPER: International Preliminary Examination Report

More information

PATENT COOPERATION TREATY (PCT)

PATENT COOPERATION TREATY (PCT) E PCT/GL/ISPE/4 ORIGINAL: ENGLISH DATE: September 30, 2015 PATENT COOPERATION TREATY (PCT) PCT INTERNATIONAL SEARCH AND PRELIMINARY EXAMINATION GUIDELINES (Guidelines for the Processing by International

More information

European Patent Office / State Intellectual Property Office of the People s Republic of China

European Patent Office / State Intellectual Property Office of the People s Republic of China European Patent Office / State Intellectual Property Office of the People s Republic of China UNITY OF INVENTION IP5 REPORT TABLE OF CONTENTS I. Introduction 5 II. Summary of the IP5 offices contributions

More information

Part IV. Fees payable on entering the European regional phase. Republication of the international application in an EPO official language

Part IV. Fees payable on entering the European regional phase. Republication of the international application in an EPO official language IV.7.5. Republication of the international application in an EPO official language PCT publication in EPO language Art.153(3) EPC The international publication of a Euro- PCT application in an official

More information

February 2015. Euro-PCT applications: Claim amendment and other issues

February 2015. Euro-PCT applications: Claim amendment and other issues February 2015 Euro-PCT applications: Claim amendment and other issues February 2015 Issues arising when PCT applications enter the regional phase in the EPO Recent years have seen numerous changes to the

More information

PATENT COOPERATION TREATY PCT. SUPPLEMENTARY INTERNATIONAL SEARCH REPORT (PCT Rule 45bis)

PATENT COOPERATION TREATY PCT. SUPPLEMENTARY INTERNATIONAL SEARCH REPORT (PCT Rule 45bis) PATENT COOPERATION TREATY PCT SUPPLEMENTARY INTERNATIONAL SEARCH REPORT (PCT Rule 45bis) Applicant s or agent s file reference International filing date (day/month/year) (Earliest) Priority Date (day/month/year)

More information

EGYPTIAN PATENT OFFICE

EGYPTIAN PATENT OFFICE PCT Applicant s Guide National Phase National Chapter EG Page 1 EGYPTIAN PATENT OFFICE AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE SUMMARY THE PROCEDURE IN THE NATIONAL

More information

Quality Management Manual Nordic Patent Institute. For the Following Processes:

Quality Management Manual Nordic Patent Institute. For the Following Processes: Quality Management Manual Nordic Patent Institute For the Following Processes: Statutory work Business Services for private customers Level 1 Policy, Goals and Organisation Version dated 30.05.2011 1 of

More information

dependent independent claims

dependent independent claims Mechanics of claim drafting Karin Pramberger Belgrade 16/17 Nov 2006 1 dependent independent claims 1. all essential features in independent claims with at least 1 novelty conferring feature 2. fall back

More information

How does the PCT work? The PCT system has two distinct phases (stages) of patent procedure the international phase, followed by the national phase. The international phase provides you with: recognition

More information

Chapter 1800 Patent Cooperation Treaty

Chapter 1800 Patent Cooperation Treaty Chapter 1800 Patent Cooperation Treaty 1801 Basic Patent Cooperation Treaty (PCT) Principles 1802 PCT Definitions 1803 Reservations Under the PCT Taken by the United States of America 1804 [Reserved] 1805

More information

Patent Cooperation Treaty (PCT)

Patent Cooperation Treaty (PCT) (PCT) Done at Washington on June 19, 1970, amended on September 28, 1979, modified on February 3, 1984, and on October 3, 2001 Editor s Note: For details concerning amendments and modifications to the

More information

REASONS FOR DECISION

REASONS FOR DECISION BL O/361/04 PATENTS ACT 1977 9 December 2004 APPLICANT Epic Systems Corporation ISSUE Whether patent application number GB 0415595.8 complies with section 1(2) HEARING OFFICER G M Rogers REASONS FOR DECISION

More information

DECISION OF THE SELECT COMMITTEE OF THE ADMINISTRATIVE COUNCIL of 15 December 2015 adopting the Rules relating to Fees for Unitary Patent Protection

DECISION OF THE SELECT COMMITTEE OF THE ADMINISTRATIVE COUNCIL of 15 December 2015 adopting the Rules relating to Fees for Unitary Patent Protection SC/D 2/15 DECISION OF THE SELECT COMMITTEE OF THE ADMINISTRATIVE COUNCIL of 15 December 2015 adopting the Rules relating to Fees for Unitary Patent Protection THE SELECT COMMITTEE OF THE ADMINISTRATIVE

More information

A Metrics Framework for the PCT

A Metrics Framework for the PCT A Metrics Framework for the PCT Wolfram Förster Principal Directorate Quality Management DG2, European Patent Office Partnership for Quality EPO - AIPLA Meeting March 2013 The PCT: A standardised system

More information

Patentability of inventions in the field of food industry: search and examination practice at the EPO

Patentability of inventions in the field of food industry: search and examination practice at the EPO 02-06-2015 Patentability of inventions in the field of food industry: search and examination practice at the EPO Marino de Terlizzi Examiner EPO, Munich June 2015 Introduction The search and examination

More information

EUROPEAN PATENT OFFICE (EPO)

EUROPEAN PATENT OFFICE (EPO) PCT Applicant s Guide National Phase National Chapter Page 1 EUROPEAN PATENT OFFICE (O) AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE SUMMARY THE PROCEDURE IN THE NATIONAL

More information

Date of decision 15 July 1986. Case number T 0208/84-3.5.1 Application number EP79300903 G06F15/20

Date of decision 15 July 1986. Case number T 0208/84-3.5.1 Application number EP79300903 G06F15/20 Date of decision 15 July 1986 Case number T 0208/84-3.5.1 Application number EP79300903 IPC G06F15/20 Procedure Language EN Title of the application Applicant name VICOM Opponent name Headnote I. Even

More information

European Patenting Practice... with a view on USPTO Differences. Michael Schneider European Patent Attorney Eversheds, Munich

European Patenting Practice... with a view on USPTO Differences. Michael Schneider European Patent Attorney Eversheds, Munich European Patenting Practice... with a view on USPTO Differences Michael Schneider European Patent Attorney Eversheds, Munich »Patents add the fuel of interest to the fire of genius«abraham Lincoln 2 Overview

More information

PATENTS ACT 1977. Whether patent application GB0706549.3 is excluded under section 1(2) of the Act DECISION

PATENTS ACT 1977. Whether patent application GB0706549.3 is excluded under section 1(2) of the Act DECISION BL O/236/12 15 June 2012 PATENTS ACT 1977 APPLICANT ISSUE Padmanabhan Mahalingham Whether patent application GB0706549.3 is excluded under section 1(2) of the Act HEARING OFFICER A Bartlett DECISION Introduction

More information

European Biotech Patent Law Update

European Biotech Patent Law Update Welcome. The Webinar will start shortly No audio is being output at this time. European Biotech Patent Law Update 23 October 2013 Presented by Robert Dempster & Simon O Brien Welcome. The Webinar has started.

More information

PATENTS ACT 1977. The Court of Edinburgh Napier University. Whether patent application number GB 1008261.8 complies with section 1(2) DECISION

PATENTS ACT 1977. The Court of Edinburgh Napier University. Whether patent application number GB 1008261.8 complies with section 1(2) DECISION BL O/164/11 16 May 2011 PATENTS ACT 1977 APPLICANT The Court of Edinburgh Napier University ISSUE Whether patent application number GB 1008261.8 complies with section 1(2) HEARING OFFICER B Micklewright

More information

BIOPATENTS IN CHINA. Christopher Shaowei Heather Lin. April 4, 2014, Budapest, Hungary 2014/4/4 NTD IP ATTORNEYS

BIOPATENTS IN CHINA. Christopher Shaowei Heather Lin. April 4, 2014, Budapest, Hungary 2014/4/4 NTD IP ATTORNEYS BIOPATENTS IN CHINA Christopher Shaowei Heather Lin April 4, 2014, Budapest, Hungary Unpatentable subject matter Art 5, Patent Law: No patent right shall be granted for any invention-creation that is contrary

More information

COUNCIL OF THE EUROPEAN UNION. Brussels, 29 September 2009 13707/09 LIMITE PI 93

COUNCIL OF THE EUROPEAN UNION. Brussels, 29 September 2009 13707/09 LIMITE PI 93 COUNCIL OF THE EUROPEAN UNION Brussels, 29 September 2009 13707/09 LIMITE PI 93 WORKING DOCUMENT from: General Secretariat of the Council to: Working Party on Intellectual Property (Patents) No. prev.

More information

PATENTS ACT 1977. Whether patent application GB0323776.5 complies with section 1(1) and 1(2) DECISION

PATENTS ACT 1977. Whether patent application GB0323776.5 complies with section 1(1) and 1(2) DECISION BL O/075/06 PATENTS ACT 1977 23 rd March 2006 APPLICANT ISSUE Elliot Klein Whether patent application GB0323776.5 complies with section 1(1) and 1(2) HEARING OFFICER H Jones DECISION Introduction 1 International

More information

INTELLECTUAL PROPERTY OFFICE (SERBIA)

INTELLECTUAL PROPERTY OFFICE (SERBIA) PCT Applicant s Guide National Phase National Chapter Page 1 INTELLECTUAL PROPERTY OFFICE (SERBIA) AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE SUMMARY THE PROCEDURE IN

More information

How to Get a Eurasian Patent

How to Get a Eurasian Patent How to Get a Eurasian Patent EURASIAN PATENT OFFICE EURASIAN PATENT OFFICE Address of the President of the Eurasian Patent Office Dear Reader, The Eurasian Patent Organization has entered the second decade

More information

Defining the Scope of Search and Examination

Defining the Scope of Search and Examination Claims Drafting : Defining the Scope of Search and Examination Kuala Lumpur, November 2011 Dr. Wolfgang Tauchert Presiding Judge (German Fed. Patent Court) ret. 1 Claims Drafting Claims Form and Function

More information

PCT FAQs. Protecting your Inventions Abroad: Frequently Asked Questions About the Patent Cooperation Treaty (PCT)

PCT FAQs. Protecting your Inventions Abroad: Frequently Asked Questions About the Patent Cooperation Treaty (PCT) PCT FAQs Protecting your Inventions Abroad: Frequently Asked Questions About the Patent Cooperation Treaty (PCT) April 2015 Overview of the PCT System Inventions are the object of International Authorities

More information

Federated Access Management

Federated Access Management Federated Access Management Document Version: 2 DRAFT Date: Oct 2011 Author (Version 2): Andrew Cormack (JANET(UK)) Authors (Version 1): Andrew Cormack (JANET(UK)), Eva Kassenaar (SURFnet), Mikael Linden

More information

Federated Access Management

Federated Access Management Federated Access Management Document Version: 10 DRAFT Date: Dec 2008 Authors: Andrew Cormack (JANET(UK)), Eva Kassenaar (formerly SURFnet), Mikael Linden (FUNET), Walter Martin Tveter (UNINETT), Abstract

More information

Yearbook. Building IP value in the 21st century. Beyond the unitary patent: nothing new under the sun?

Yearbook. Building IP value in the 21st century. Beyond the unitary patent: nothing new under the sun? Beyond the unitary patent: nothing new under the sun? Anna Barlocci and Mathieu de Rooij, ZBM Patents & Trademarks Yearbook 2015 Building IP value in the 21st century 12 13 14 ZBM Patents & Trademarks

More information

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof; DIRECTIVE 65/65/EEC Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ L No 22 of

More information

Annex I Common Requirements for All Types of Documents

Annex I Common Requirements for All Types of Documents Annex I Common Requirements for All Types of Documents Prepared by the Trilateral Offices 30 November 2007 1. Common Requirements for All Types of Documents The Working Group agreed on the followings specific

More information

EURASIAN PATENT OFFICE (EAPO)

EURASIAN PATENT OFFICE (EAPO) PCT Applicant s Guide National Phase National Chapter Page 1 EURASIAN PATENT OFFICE (PO) AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE SUMMARY THE PROCEDURE IN THE NATIONAL

More information

Decision of Technical Board of Appeal 3.5.1 dated 21 April 2004 T 258/03-3.5.1

Decision of Technical Board of Appeal 3.5.1 dated 21 April 2004 T 258/03-3.5.1 ET0258.03-042040020 1 Decision of Technical Board of Appeal 3.5.1 dated 21 April 2004 T 258/03-3.5.1 (Language of the proceedings) Composition of the Board: Chairman: Members: S. V. Steinbrener R. S. Wibergh

More information

HOW TO REGISTER PATENTS IN NAMIBIA

HOW TO REGISTER PATENTS IN NAMIBIA filing the Provisional Specification (or after the priority date, in the case of a convention application), the date of any patent grantable on the application by virtue of such Claims would run from the

More information

Regulations under the Patent Cooperation Treaty. (as in force from July 1, 2015)

Regulations under the Patent Cooperation Treaty. (as in force from July 1, 2015) Regulations under the Patent Cooperation Treaty (as in force from July 1, 2015) Editor s Note: For details concerning amendments to the Regulations under the Patent Cooperation Treaty, and for access to

More information

Computer-Implemented Inventions EPO

Computer-Implemented Inventions EPO Computer-Implemented Inventions EPO Sept 2013 European Patent Convention What is an Invention? Patentable Inventions Patentable Inventions European patents shall be granted for - any inventions, in all

More information

Second medical use patents

Second medical use patents Second medical use patents The European Swiss perspective AIPPI Helsinki 2013, Pharma Workshop II Andri Hess Part 1 Second medical use claims the protection they confer 2 Second (or further) medical use

More information

IN THE MATTER OF International Application No PCT/GB 2003/002308 in the name of PENIFE INTERNATIONAL LIMITED

IN THE MATTER OF International Application No PCT/GB 2003/002308 in the name of PENIFE INTERNATIONAL LIMITED PATENT COOPERATION TREATY IN THE MATTER OF International Application No PCT/GB 2003/002308 in the name of PENIFE INTERNATIONAL LIMITED DECISION Introduction 1 The United Kingdom Patent Office acting as

More information

Chapter Two Procedure on the Application for an Invention

Chapter Two Procedure on the Application for an Invention CZECH REPUBLIC Patent Regulations Decree of the Industrial Property Office on the Procedure in Matters of Inventions and Industrial Designs No. 550 of December 11, 1990 ENTRY INTO FORCE: January 1, 1991

More information

PCT PRACTICE International Applications Filed Prior to January 1, 2004

PCT PRACTICE International Applications Filed Prior to January 1, 2004 International Applications Filed Prior to January 1, 2004 I. Introduction The PCT (Patent Cooperation Treaty) is an international agreement for the purpose of unifying and simplifying the procedures for

More information

Patent issues in Industrial Biotech:

Patent issues in Industrial Biotech: Patent issues in Industrial Biotech: Nucleic Acids, Life Forms & Natural Products Konrad Sechley PhD, Vancouver, Canada 18 April, 2016 OVERVIEW Gene patenting Life Forms & Natural Products Conclusions

More information

The Intellectual Property System in Ethiopia

The Intellectual Property System in Ethiopia The Intellectual Property System in Ethiopia By Wondwossen Belete Ethiopian Intellectual Property Office December 2004 Addis Ababa The explanations in this presentation cover: The Legal Framework for the

More information

PATENTS ACT 1977. Whether patent application GB 2383152 A relates to a patentable invention DECISION

PATENTS ACT 1977. Whether patent application GB 2383152 A relates to a patentable invention DECISION BL O/255/05 PATENTS ACT 1977 14 th September 2005 APPLICANT Oracle Corporation ISSUE Whether patent application GB 2383152 A relates to a patentable invention HEARING OFFICER Stephen Probert DECISION Introduction

More information

Qualifications for registration as a Patent Agent

Qualifications for registration as a Patent Agent ROLES AND FUNCTIONS OF PATENT AGENTS The roles and functions of Patent Agents are determined by the domestic legislation of the territories and countries in which Patent Agents are registered to practice.

More information

The Patents Rules 2007 (as amended)

The Patents Rules 2007 (as amended) The Patents Rules 2007 (as amended) The Patents (Fees) Rules 2007 (as amended) An unofficial consolidation produced by Patents Legal Section 1 October 2014 Intellectual Property Office is an operating

More information

IP Litigation in Europe and in Germany

IP Litigation in Europe and in Germany & P A R T N E R P A T E N T A T T O R N E Y S D Ü S S E L D O R F M U N I C H IP Litigation in Europe and in Germany Dr. Dirk Schulz Outline - Patent litigation in Europe - German patent litigation system

More information

QUESTIONS AND ANSWERS REGARDING JAPANESE PATENT PRACTICE TABLE OF CONTENTS

QUESTIONS AND ANSWERS REGARDING JAPANESE PATENT PRACTICE TABLE OF CONTENTS QUESTIONS AND ANSWERS REGARDING JAPANESE PATENT PRACTICE TABLE OF CONTENTS QUESTIONS AND ANSWERS compiled by the International Activities Center of the Japan Patent Attorneys Association I. APPLICATION

More information

The Consolidate Patents Act 1)

The Consolidate Patents Act 1) Consolidate Act No. 108 of 24 January 2012 The Consolidate Patents Act 1) Publication of the Patents Act, cf. Consolidate Act No. 91 of 28 January 2009 as amended by section 20 of Act No. 579 of 1 June

More information

PATENTS. Pharmaceutical Product Patenting Strategies

PATENTS. Pharmaceutical Product Patenting Strategies PATENTS Pharmaceutical Product Patenting Strategies 1. What is a product patent? A product patent is a patent giving protection to a product as such, e.g. as an apparatus, a device or a chemical compound.

More information

USPTO Fees - FY 2003

USPTO Fees - FY 2003 USPTO Fees - FY 2003 UNITED STATES PATENT AND TRADEMARK OFFICE Effective January 1, 2003 Any fee amount paid on or after January 1, 2003, must be paid in the revised amount. The fees subject to reduction

More information

How To Allow A Chiropractor To Perform Anesthetic Manipulation

How To Allow A Chiropractor To Perform Anesthetic Manipulation STATE OF CALIFORNIA OFFICE OF ADMINISTRATIVE LAW AGENCY: BOARD OF CHIROPRACTIC ) DECISION OF DISAPPROVAL EXAMINERS ) OF REGULATORY ACTION ) ) (Gov. Code, sec. 11349.3) ) ) OAL File No. 05-0826-03 S ACTION:

More information

6. We believe that the Guidance does not accord with TRIPs. Any administrative or judicial interpretation of the provisions of any statute,

6. We believe that the Guidance does not accord with TRIPs. Any administrative or judicial interpretation of the provisions of any statute, 2014 PROCEDURE FOR SUBJECT MATTER ELIGIBILITY ANALYSIS OF CLAIMS RECITING OR INVOLVING LAWS OF NATURE/NATURAL PRINCIPLES, NATURAL PHENOMENA, AND/OR NATURAL PRODUCTS COMMENTS OF PROFESSOR PAUL COLE AND

More information

Subject : April Referral G 03 / 08 Case G03/08 Referral under Article 112(1)b) EPC ("Patentability of programs for computers")

Subject : April Referral G 03 / 08 Case G03/08 Referral under Article 112(1)b) EPC (Patentability of programs for computers) Enlarged Board of Appeal European Patent Office Erhardtstrasse 27 80331 München Paris, April 29 th, 2009 Subject : April Referral G 03 / 08 Case G03/08 Referral under Article 112(1)b) EPC ("Patentability

More information

PATENTS ACT 1977. IN THE MATTER OF Application No. GB 9808661.4 in the name of Pintos Global Services Ltd DECISION. Introduction

PATENTS ACT 1977. IN THE MATTER OF Application No. GB 9808661.4 in the name of Pintos Global Services Ltd DECISION. Introduction PATENTS ACT 1977 IN THE MATTER OF Application No. GB 9808661.4 in the name of Pintos Global Services Ltd DECISION Introduction 1. Patent application number GB 9808661.4 entitled, A system for exchanging

More information

Maine Cernota & Rardin, Registered Patent Attorneys 547 Amherst St., 3 rd Floor, Nashua, NH 03063 603-886-6100 info@mcr-ip.com

Maine Cernota & Rardin, Registered Patent Attorneys 547 Amherst St., 3 rd Floor, Nashua, NH 03063 603-886-6100 info@mcr-ip.com Glossary of IP Terms Term Abstract of the Disclosure (AKA Abstract) America Invents Act (AKA the AIA) Application (patent) Application Number (patent) Assignment Claims Continuation in Part (CIP) Definition

More information

Patents for software?

Patents for software? European Patent Office Munich Headquarters Erhardtstr. 27 80469 Munich Germany Tel. + 49 (0) 89 2399-0 Fax + 49 (0) 89 2399-4560 The Hague Patentlaan 2 2288 EE Rijswijk Netherlands Tel. + 31 (0) 70 340-2040

More information

GUIDELINES FOR PATENT EXAMINATION IN THE INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA

GUIDELINES FOR PATENT EXAMINATION IN THE INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA GUIDELINES FOR PATENT EXAMINATION IN THE INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA OCTOBER 2011 i GUIDELINES FOR PATENT EXAMINATION MANUAL IN THE INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA CONTENTS

More information

The Patents Act 1977 (as amended)

The Patents Act 1977 (as amended) The Patents Act 1977 (as amended) An unofficial consolidation produced by Patents Legal Section 1 October 2014 Intellectual Property Office is an operating name of the Patent Office Note to users This

More information

Technical Protective Rights in Europe

Technical Protective Rights in Europe Technical Protective Rights in Europe Patent Protection in Europe A Brief Introduction The European Patent The European Patent Convention (EPC) provides patent coverage throughout the countries of the

More information

STATE INTELLECTUAL PROPERTY OFFICE OF THE PEOPLE S REPUBLIC OF CHINA

STATE INTELLECTUAL PROPERTY OFFICE OF THE PEOPLE S REPUBLIC OF CHINA CN PCT Applicant s Guide National Phase National Chapter CN Page 1 STATE INTELLECTUAL PROPERTY OFFICE OF THE PEOPLE S REPUBLIC OF CHINA AS DESIGNATED (OR ELECTED) OFFICE TABLE OF CONTENTS THE ENTRY INTO

More information

Meeting of International Authorities under the Patent Cooperation Treaty (PCT)

Meeting of International Authorities under the Patent Cooperation Treaty (PCT) E PCT/MIA/21/20 ORIGINAL: ENGLISH ONLY DATE: FEBRUARY 4, 2014 Meeting of International Authorities under the Patent Cooperation Treaty (PCT) Twenty-First Session Tel Aviv, February 11 to 13, 2014 TRANSLATION

More information

CANADA Patent Rules as amended by SOR/2007-90

CANADA Patent Rules as amended by SOR/2007-90 CANADA Patent Rules as amended by SOR/2007-90 TABLE OF CONTENTS 1. SHORT TITLE 2. INTERPRETATION PART I RULES OF GENERAL APPLICATION 3. Fees 3.01 3.02 3.1 4. 5. Communications 6. 7. 8. 9. 10. 11. 12. Entry

More information

APPLICATION FOR GRANT OF PATENT

APPLICATION FOR GRANT OF PATENT FORM 1 (FOR OFFICE USE ONLY) THE PATENTS ACT 1970 (39 of 1970) and THE PATENTS RULES, 2003 APPLICATION FOR GRANT OF PATENT (See section 7, 54 and 135 and sub-rule (1) of rule 20) Application No. Filing

More information

PPH using the PCT international work products from the JPO

PPH using the PCT international work products from the JPO Part II using the international work products from the JPO Part II using the international work products from the JPO Applicants can request accelerated examination by a prescribed procedure including

More information

Chapter 2 Fields of Intellectual Property Protection

Chapter 2 Fields of Intellectual Property Protection Chapter 2 Fields of Intellectual Property Protection Patents Introduction Conditions of Patentability Drafting and Filing a Patent Application Examination of a Patent Application Infringement Exploitation

More information

Guide to WIPO Services

Guide to WIPO Services World Intellectual Property Organization Guide to WIPO Services Helping you protect inventions, trademarks & designs resolve domain name & other IP disputes The World Intellectual Property Organization

More information

The table below only lists the amended provisions of the Directive. Please refer to the attached draft DCG for an overview of the amended Directive.

The table below only lists the amended provisions of the Directive. Please refer to the attached draft DCG for an overview of the amended Directive. Table of changes to the DCG Directive on Information relating to Corporate Governance (DCG) General considerations: The table below only lists the amended provisions of the Directive. Please refer to the

More information

Ryerson Digital Media Zone Online Resources Patent Essentials

Ryerson Digital Media Zone Online Resources Patent Essentials Maya Medeiros Lawyer, Patent Agent, Trademark Agent T: +1 416.216.4823 maya.medeiros@nortonrosefulbright.com http://www.nortonrosefulbright.com/people/99601/maya- medeiros PATENT ESSENTIALS WHAT IS A PATENT?

More information

Training for Patent Professionals EQE BASIC LEGAL DISTANCE LEARNING

Training for Patent Professionals EQE BASIC LEGAL DISTANCE LEARNING Training for Patent Professionals EQE BASIC LEGAL DISTANCE LEARNING www.deltapatents.com 02 DELTAPATENTS WELCOMES YOU Why DeltaPatents? DeltaPatents is a patent attorney firm based in the Netherlands with

More information

Experiences with the Patent Prosecution Highway (PPH) at the USPTO

Experiences with the Patent Prosecution Highway (PPH) at the USPTO Experiences with the Patent Prosecution Highway (PPH) at the USPTO Tel Aviv, Israel Paolo Trevisan Patent Attorney Office of Policy and International Affairs United States Patent and Trademark Office 1

More information

PENDING CLASS ADVANCE WAIVER PROVISIONS

PENDING CLASS ADVANCE WAIVER PROVISIONS PENDING CLASS ADVANCE WAIVER PROVISIONS A Class Advance Waiver for FastForward Subcontracts is pending authorization by the Department of Energy. Upon receipt of that authorization, LLNS will amend the

More information

Scuola di dottorato in Scienze molecolari Information literacy in chemistry 2015. Patents

Scuola di dottorato in Scienze molecolari Information literacy in chemistry 2015. Patents Patents a patent is a right granted by a government to an inventor for a limited time inventions become public domain after 20 years to be patentable an invention must meet the following criteria: usefulness:

More information

(Notices) COUNCIL AGREEMENT. on a Unified Patent Court (2013/C 175/01)

(Notices) COUNCIL AGREEMENT. on a Unified Patent Court (2013/C 175/01) 20.6.2013 Official Journal of the European Union C 175/1 IV (Notices) NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES COUNCIL AGREEMENT on a Unified Patent Court (2013/C 175/01)

More information

Sharing patenting expertise and experiences

Sharing patenting expertise and experiences Sharing patenting expertise and experiences Training catalogue 2015 European Patent Academy Foreword With nearly 40 conferences, seminars, workshops and webinars, in 2015 the European Patent Academy will

More information

PLANT VARIETIES PROTECTION ACT (CHAPTER 232A, SECTION 54) PLANT VARIETIES PROTECTION RULES

PLANT VARIETIES PROTECTION ACT (CHAPTER 232A, SECTION 54) PLANT VARIETIES PROTECTION RULES CAP. 232A, R 1] Plant Varieties Protection Rules [2006 Ed. p. 1 PLANT VARIETIES PROTECTION ACT (CHAPTER 232A, SECTION 54) PLANT VARIETIES PROTECTION RULES Rule 1. Citation 2. Definitions 3. Fees 4. Forms

More information

MEDICAL/PHARMACEUTICAL INVENTIONS. A comparative study Europe China

MEDICAL/PHARMACEUTICAL INVENTIONS. A comparative study Europe China GLOBAL I.P. & INNOVATION SUMMIT SHANGHAI 4-5 SEPTEMBER 2013 MEDICAL/PHARMACEUTICAL INVENTIONS A comparative study Europe China Claudio Germinario claudio.germinario@sib.it SOCIETÀ ITALIANA BREVETTI www.sib.it

More information

INTERNATIONAL STANDARD ON AUDITING (UK AND IRELAND) 700 THE AUDITOR S REPORT ON FINANCIAL STATEMENTS CONTENTS

INTERNATIONAL STANDARD ON AUDITING (UK AND IRELAND) 700 THE AUDITOR S REPORT ON FINANCIAL STATEMENTS CONTENTS INTERNATIONAL STANDARD ON AUDITING (UK AND IRELAND) 700 THE AUDITOR S REPORT ON FINANCIAL STATEMENTS CONTENTS Paragraphs Introduction... 1-4 Basic Elements of the Auditor s Report... 5-26-1 The Auditor

More information

INTERNATIONAL STANDARD ON AUDITING 700 FORMING AN OPINION AND REPORTING ON FINANCIAL STATEMENTS CONTENTS

INTERNATIONAL STANDARD ON AUDITING 700 FORMING AN OPINION AND REPORTING ON FINANCIAL STATEMENTS CONTENTS INTERNATIONAL STANDARD ON 700 FORMING AN OPINION AND REPORTING ON FINANCIAL STATEMENTS (Effective for audits of financial statements for periods beginning on or after December 15, 2009) CONTENTS Paragraph

More information

CANADIAN PATENT AGENT QUALIFYING EXAMINATION GUIDE TO WRITING THE PATENT AGENT EXAM PAPER A PATENT DRAFTING

CANADIAN PATENT AGENT QUALIFYING EXAMINATION GUIDE TO WRITING THE PATENT AGENT EXAM PAPER A PATENT DRAFTING CANADIAN PATENT AGENT QUALIFYING EXAMINATION PAPER A PATENT DRAFTING These guidelines describe in a general manner the contents and criteria for the Patent Agent Examination - Paper A. Specific content

More information

Decree on Utility Model Rights

Decree on Utility Model Rights 1 NB: Unofficial translation FINLAND Decree on Utility Model Rights (1419/1991; amendments up to 119/1996 included) Utility Model Applications and Record of Applications Section 1 A utility model application

More information

This is consistent with our guidance in Good medical practice, which says:

This is consistent with our guidance in Good medical practice, which says: 26 August 2014 Bill Rogers Competition and Markets Authority Dear Bill Rogers, Draft Order Thank you for meeting my colleague Catherine Thomas to discuss your Order. This letter is our formal response.

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, EMA Brussels, 27.03.2014 ENTR/6283/00 Rev 4 orphan\guidelines\format content

More information

Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Executive Summary

Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Executive Summary Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Executive Summary Introduction Biomedical researchers have long studied human biological materials such as cells collected

More information

Background. Audit Quality and Public Interest vs. Cost

Background. Audit Quality and Public Interest vs. Cost Basis for Conclusions: ISA 600 (Revised and Redrafted), Special Considerations Audits of Group Financial Statements (Including the Work of Component Auditors) Prepared by the Staff of the International

More information

Comments on Draft Guidelines. for Examination of. Patent Applications in the Field of Pharmaceuticals. before the Indian Patent Office (IPO)

Comments on Draft Guidelines. for Examination of. Patent Applications in the Field of Pharmaceuticals. before the Indian Patent Office (IPO) Where Technology, Law and Business Intersect TECH CORP LEGAL LLP PATENT ADVOCATES & INTERNATIONAL LEGAL CONSULTANTS Comments on Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals

More information

INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA

INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA Page 1 INTELLECTUAL PROPERTY CORPORATION OF MALAYSIA AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE SUMMARY THE PROCEDURE IN THE NATIONAL PHASE ANNEXES Fees... Annex MY.I

More information

International Paralympic Committee Medical Code. December 2011

International Paralympic Committee Medical Code. December 2011 International Paralympic Committee Medical Code December 2011 This version of the IPC Medical Code has been approved by the IPC General Assembly December 2011. IPC Medical Code 1 Preamble 1. The Paralympic

More information

Official Journal of the European Union. (Acts whose publication is obligatory)

Official Journal of the European Union. (Acts whose publication is obligatory) 27.12.2006 L 378/1 I (Acts whose publication is obligatory) REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 12 December 2006 on medicinal products for paediatric use and amending

More information

REGULATION (EEC) No 2309/93

REGULATION (EEC) No 2309/93 REGULATION (EEC) No 2309/93 Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use

More information

Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA

Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions

More information

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS Medical Examiners Chapter 540-X-8 ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS 540-X-8-.01 540-X-8-.02 540-X-8-.03

More information

Ordinance on Specialised Waste Management Companies (Entsorgungsfachbetriebeverordnung - EfbV) *) of 10 September 1996

Ordinance on Specialised Waste Management Companies (Entsorgungsfachbetriebeverordnung - EfbV) *) of 10 September 1996 Ordinance on Specialised Waste Management Companies (Entsorgungsfachbetriebeverordnung - EfbV) *) of 10 September 1996 The Federal Government, having heard the parties concerned, and pursuant to Article

More information

AUSTRIAN PATENT OFFICE

AUSTRIAN PATENT OFFICE PCT Applicant s Guide National Phase National Chapter Page 1 AUSTRIAN PENT OFFICE AS DESIGNED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NIONAL PHASE SUMMARY THE PROCEDURE IN THE NIONAL PHASE ANNEXES

More information

R156. Commerce, Occupational and Professional Licensing. R156-28. Veterinary Practice Act Rule. R156-28-101. Title. R156-28-102. Definitions.

R156. Commerce, Occupational and Professional Licensing. R156-28. Veterinary Practice Act Rule. R156-28-101. Title. R156-28-102. Definitions. R156. Commerce, Occupational and Professional Licensing. R156-28. Veterinary Practice Act Rule. R156-28-101. Title. This rule is known as the "Veterinary Practice Act Rule". R156-28-102. Definitions. In

More information

AGREEMENT ON TECHNICAL BARRIERS TO TRADE. Having regard to the Uruguay Round of Multilateral Trade Negotiations;

AGREEMENT ON TECHNICAL BARRIERS TO TRADE. Having regard to the Uruguay Round of Multilateral Trade Negotiations; Page 117 AGREEMENT ON TECHNICAL BARRIERS TO TRADE Members, Having regard to the Uruguay Round of Multilateral Trade Negotiations; Desiring to further the objectives of GATT 1994; Recognizing the important

More information

REPUBLIC ACT NO. 8293

REPUBLIC ACT NO. 8293 REPUBLIC ACT NO. 8293 AN ACT PRESCRIBING THE INTELLECTUAL PROPERTY CODE AND ESTABLISHING THE INTELLECTUAL PROPERTY OFFICE, PROVIDING FOR ITS POWERS AND FUNCTIONS, AND FOR OTHER PURPOSES PART I The Intellectual

More information

UNITED STATES DEPARTMENT OF THE INTERIOR BUREAU OF LAND MANAGEMENT MANUAL TRANSMITTAL SHEET MS 1221 DIRECTIVES MANUAL

UNITED STATES DEPARTMENT OF THE INTERIOR BUREAU OF LAND MANAGEMENT MANUAL TRANSMITTAL SHEET MS 1221 DIRECTIVES MANUAL Form 1221-2 (June 1969) Subject UNITED STATES DEPARTMENT OF THE INTERIOR BUREAU OF LAND MANAGEMENT MANUAL TRANSMITTAL SHEET MS 1221 DIRECTIVES MANUAL Release 1-1759 Date 7/25/2014 1. Explanation of Materials

More information